These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 30954641

  • 1. Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS.
    Lemal R, Fouquet G, Terriou L, Vaes M, Livideanu CB, Frenzel L, Barete S, Canioni D, Lhermitte L, Rossignol J, Arock M, Dubreuil P, Lortholary O, Hermine O.
    J Allergy Clin Immunol Pract; 2019; 7(7):2387-2395.e3. PubMed ID: 30954641
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study).
    Distler M, Maul JT, Steiner UC, Jandus P, Kolios AGA, Murer C, Graf N, Seebach JD, Pichler WJ, Navarini AA, French LE, Helbling A, Schmid-Grendelmeier P.
    Dermatology; 2020; 236(6):529-539. PubMed ID: 31958790
    [Abstract] [Full Text] [Related]

  • 4. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M, Butterfield J.
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [Abstract] [Full Text] [Related]

  • 5. Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.
    Jendoubi F, Gaudenzio N, Gallini A, Negretto M, Paul C, Bulai Livideanu C.
    Clin Exp Allergy; 2020 Jun; 50(6):654-661. PubMed ID: 32107810
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?
    Kacar M, Denman S, Savic S.
    J Investig Allergol Clin Immunol; 2018 Aug; 28(4):261-263. PubMed ID: 30073959
    [No Abstract] [Full Text] [Related]

  • 9. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
    Giannetti MP, Weller E, Bormans C, Novak P, Hamilton MJ, Castells M.
    Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial.
    Casale TB, Condemi J, LaForce C, Nayak A, Rowe M, Watrous M, McAlary M, Fowler-Taylor A, Racine A, Gupta N, Fick R, Della Cioppa G, Omalizumab Seasonal Allergic Rhinitis Trail Group.
    JAMA; 2001 Dec 19; 286(23):2956-67. PubMed ID: 11743836
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.
    Kaplan AP, Giménez-Arnau AM, Saini SS.
    Allergy; 2017 Apr 19; 72(4):519-533. PubMed ID: 27861988
    [Abstract] [Full Text] [Related]

  • 20. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
    Jachiet M, Samson M, Cottin V, Kahn JE, Le Guenno G, Bonniaud P, Devilliers H, Bouillet L, Gondouin A, Makhlouf F, Meaux-Ruault N, Gil H, Bienvenu B, Coste A, Groh M, Giraud V, Dominique S, Godeau B, Puéchal X, Khouatra C, Ruivard M, Le Jeunne C, Mouthon L, Guillevin L, Terrier B, French Vasculitis Study Group.
    Arthritis Rheumatol; 2016 Sep 19; 68(9):2274-82. PubMed ID: 26946346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.